Gardy & Notis, LLP is a court appointed lead counsel for stockholders suing McKesson Corporation's officers and directors for breach of their fiduciary obligations to the company by failing to provide oversight of McKesson's compliance with the Controlled Substances Act and related regulations.

Gardy & Notis, LLP is the court appointed lead counsel for investors who bought American Depositary Shares (ADS) and options of Shire plc between September 29, 2014 and October 14, 2014. Gardy & Notis, LLP pursued claims that AbbVie, Inc. and its Chief Executive Officer defrauded Shire plc investors by making false statements regarding AbbVie's planned merger with Shire.

Gardy & Notis, LLP is lead counsel for investors suing the board of directors of McKesson Corporation and other corporate insiders for breaching their fiduciary obligations in failing to monitor suspicious sales of controlled substance pharmaceuticals and report suspicious sales as required by the Controlled Substances Act.

Gardy & Notis, LLP is lead counsel for the former public stockholders of Handy & Harman Ltd. whose shares were merged out by Handy & Harman's majority stockholder, Steel Partners Holdings, L.P.

Gardy & Notis, LLP served as lead counsel for former stockholders of Comverge, Inc. challenging the acquisition of Comverge by a subsidiary of H.I.G. Capital, LLC for $1.75 cash per share.

Gardy & Notis, LLP has been appointed as lead counsel for Medtronic stockholders in a class action challenging Medtronic's merger with Covidien. The merger was structured as a reverse merger tax inversion, whereby Medtronic would emerge as a new entity incorporated in Ireland to avoid paying U.S. corporate income taxes.

Gardy & Notis, LLP has been appointed by the Court as lead counsel for former stockholders of Sauer-Danfoss, Inc. challenging a conflicted transaction whereby Sauer-Danfoss's controlling stockholder, Danfoss A/S, merged out public stockholders for $58.50 per share.

Gardy & Notis, LLP has been appointed as lead counsel for investors who bought ShireAmerican Depositary Shares (ADS) between September 29, 2014 and October 14, 2014.AbbVie and Shire entered into a Combination Agreement on July 18, 2014 for a tax inversion where AbbVie would merge with and into Shire and reincorporate in Ireland to avoid paying U.S. corporate income taxes.

Gardy & Notis, LLP has been appointed by the Court as lead counsel for former stockholders of Primedia, Inc. challenging the merger of Primedia with affiliates of TPG Capital L.P. The case alleges that Kolberg Kravis Roberts & Co. L.P. and other Primedia insiders agreed to sell Primedia to another private equity firm, TPG Capital L.P., for an unfair price of $7.10 per share. The $7.10 per share merger price was recommended by an independent committee of Primedia's board of directors and approved by the full board. Plaintiff alleged that the merger price failed to reflect the value of derivative claims seeking disgorgement of KKR's insider profits from trades in Primedia securities at depressed prices.

Gardy & Notis, LLP is co-lead counsel for bondholders who own 6.50% Senior Notes due 2016 issued by Caesars Entertainment Operating Corporation (CEOC) and guaranteed by Caesars Entertainment Corporation (CEC).The 2016 Senior Notes were issued by CEOC pursuant to a June 9, 2006 indenture.The complaint alleges that CEOC and CEC violated the Trust Indenture Act of 1939, 15 U.S.C. §§77aaa, et seq., breached the 2016 indenture and the covenant of good faith and fair dealing when CEOC and CEC entered into a transaction to release CEC from its guarantee obligation on the 2016 Senior Notes as part of a scheme to protect CEC and its private equity sponsors ahead of a planned bankruptcy for CEOC.